Gottlieb rebuts Science report on plummeting FDA inspections; Libtayo wins EMA and NICE endorsement
→ The journal Science on Tuesday published a report that concluded the FDA’s compliance and enforcement actions have plummeted since Donald Trump took office, using data compiled from the agency’s own public records.
In response, Scott Gottlieb — who recently exited the agency as Trump’s first FDA commissioner — defended his record. “We were pretty aggressive,” he wrote to Science. “I don’t think you can paint us with a political narrative—that just because we were a Republican administration, somehow we must have ratcheted down enforcement activity. We didn’t.” Gottlieb, much like the majority of former FDA commissioners that preceded him, has joined the industry he once regulated. Last week, he accepted a position on Pfizer‘s $PFE board of directors, sparking a storm of criticism after taking the fastest route between commissioner and big pharma seen in the agency’s history.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.